Literature DB >> 33188956

ALDH2 mutation promotes skeletal muscle atrophy in mice via accumulation of oxidative stress.

Hiroki Kobayashi1, Satoshi Nakamura1, Yuiko Sato2, Tami Kobayashi3, Kana Miyamoto4, Akihito Oya1, Morio Matsumoto1, Masaya Nakamura1, Arihiko Kanaji5, Takeshi Miyamoto6.   

Abstract

Muscle atrophy is promoted by various factors including aging, immobilization, unloading and use of drugs such as steroids. However, genetic risk factors for muscle atrophy are less well known. Here, we show that a missense SNP in the ALDH2 gene, rs671 (ALDH2*2), a dominant negative mutation, promotes significant muscle atrophy in the ALDH2*2 mouse model, accompanied by decreased expression of anabolic and catabolic muscle factors and acquisition of a low turnover state. We also demonstrate that expression of LC3, which is require for auto-phagosome formation during autophagy, increases in ALDH2*2 mouse muscles. We show that 4-hydroxynonenal (4HNE), a peroxidated lipid-protein and oxidant, accumulates in ALDH2*2 mouse muscles. We have shown that the rs671 mutation is associated with increased serum levels of acetaldehyde, an alcohol metabolite. We show that expression of the atrogenes Atrogin1 and MuRF1 significantly increased in myogenic cells following acetaldehyde treatment, an outcome significantly inhibited in vitro by Trolox C, an anti-oxidant. Muscle atrophy in ALDH2*2 mice was also significantly rescued by dietary administration of the anti-oxidant vitamin E, which blocked 4HNE accumulation in muscle. Taken together, our data indicate that rs671 is a genetic risk factor for muscle atrophy, but that such atrophy can be rescued by vitamin E treatment.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALDH2; Muscle atrophy; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 33188956     DOI: 10.1016/j.bone.2020.115739

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  3 in total

Review 1.  Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention.

Authors:  Jie Gao; Yue Hao; Xiangshu Piao; Xianhong Gu
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

2.  Hao1 Is Not a Pathogenic Factor for Ectopic Ossifications but Functions to Regulate the TCA Cycle In Vivo.

Authors:  Atsushi Kimura; Akiyoshi Hirayama; Tatsuaki Matsumoto; Yuiko Sato; Tami Kobayashi; Satsuki Ikeda; Midori Maruyama; Mari Kaneko; Mayo Shigeta; Eri Ito; Tomoya Soma; Kana Miyamoto; Tomoyoshi Soga; Masaru Tomita; Akihito Oya; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  Metabolites       Date:  2022-01-15

3.  Aldehyde dehydrogenase 2 alleviates monosodium iodoacetate-induced oxidative stress, inflammation and apoptosis in chondrocytes via inhibiting aquaporin 4 expression.

Authors:  Lingxiao Pan; Wei Ding; Jie Li; Kaifeng Gan; Yandong Shen; Junxiang Xu; Minzhe Zheng
Journal:  Biomed Eng Online       Date:  2021-08-06       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.